Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304793 · ClinicalTrials.gov registry record · NA
Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05304793 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 46 participants.
The verdict
NCT05304793, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This trial studies the effect of a form of cognitive-behavioral therapy, Take a Breath, on reducing the intensity and frequency of dyspnea (difficulty breathing) in patients with lung cancer. Take a Breath consists of individual therapy sessions that educate patients on dyspnea and provides coping strategies.
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- BEHAVIORAL Cognitive Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2021-07-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05304793
The ClinicalTrials.gov registry entry for NCT05304793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05304793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05304793 about?
NCT05304793 is a clinical study titled "Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer". This trial studies the effect of a form of cognitive-behavioral therapy, Take a Breath, on reducing the intensity and frequency of dyspnea (difficulty breathing) in patients with lung cancer. Take a Breath consists of individual therapy sessions that educate patients on dyspnea and provides coping s...
What is the current status of trial NCT05304793?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2020-07-01. Estimated completion is 2021-07-16.
What interventions are being tested in trial NCT05304793?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Cognitive Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05304793?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.